Global Medical REIT Inc. financial data

Symbol
GMRE, GMRE-PA, GMRE-PB on NYSE
Location
Bethesda, MD
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 02 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 148% % 21%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13,234,830 shares -80%
Common Stock, Shares, Outstanding 13,234,830 shares -1%
Entity Public Float $436,000,000 USD -22%
Common Stock, Value, Issued $13,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 13,379,000 shares 1.5%
Weighted Average Number of Shares Outstanding, Diluted 13,379,000 shares 1.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $148,208,000 USD 6.8%
General and Administrative Expense $19,998,000 USD -5.3%
Earnings Per Share, Basic -0.91 USD/shares -1617%
Earnings Per Share, Diluted -0.91 USD/shares -1617%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $9,084,000 USD 33%
Operating Lease, Right-of-Use Asset $13,102,000 USD 80%
Goodwill $5,903,000 USD 0%
Assets $1,242,465,000 USD -1.1%
Employee-related Liabilities, Current $3,200,000 USD
Liabilities $712,400,000 USD 1.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax $6,102,000 USD -67%
Retained Earnings (Accumulated Deficit) $349,965,000 USD -19%
Stockholders' Equity Attributable to Parent $509,770,000 USD -4.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $530,065,000 USD -4.6%
Liabilities and Equity $1,242,465,000 USD -1.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $12,272,000 USD -14%
Net Cash Provided by (Used in) Financing Activities $13,598,000 USD
Net Cash Provided by (Used in) Investing Activities $27,224,000 USD -902%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 13,235,000 shares -1%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,354,000 USD -225%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $11,889,000 USD 33%
Interest Paid, Excluding Capitalized Interest, Operating Activities $6,568,000 USD 2.5%
Operating Lease, Liability $13,438,000 USD 80%
Depreciation $44,025,000 USD 8.9%
Lessee, Operating Lease, Liability, to be Paid $31,850,000 USD 150%
Property, Plant and Equipment, Gross $1,492,752,000 USD 2.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,150,000 USD 52%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,134,000 USD 53%
Operating Lease, Weighted Average Discount Rate, Percent 0.075 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $18,412,000 USD 250%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,174,000 USD 52%
Preferred Stock, Shares Issued 5,155,000 shares 66%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,193,000 USD 50%
Operating Lease, Payments $272,000 USD 85%
Additional Paid in Capital $729,514,000 USD -0.65%
Preferred Stock, Shares Outstanding 5,155,000 shares 66%
Interest Expense $29,512,000 USD 2.8%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%